128 related articles for article (PubMed ID: 2576239)
1. Restriction fragment length polymorphism of the c-Ha-ras-1 proto-oncogene as a marker of genome alterations and susceptibility to the development of some human carcinomas.
Knyazev PG; Nikiforova IF; Serova OM; Novikov LB; Pluzhnikova GF; Abramov AM; Seitz JF
Haematol Blood Transfus; 1989; 32():433-5. PubMed ID: 2576239
[No Abstract] [Full Text] [Related]
2. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
[TBL] [Abstract][Full Text] [Related]
3. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
[TBL] [Abstract][Full Text] [Related]
4. Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma.
Ceccherini-Nelli L; De Re V; Viel A; Molaro G; Zilli L; Clemente C; Boiocchi M
Br J Cancer; 1987 Jul; 56(1):1-5. PubMed ID: 2887194
[TBL] [Abstract][Full Text] [Related]
5. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
[TBL] [Abstract][Full Text] [Related]
6. [Genetic polymorphism and susceptibility to cancer].
Larsen CJ
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.
Zborovskaya I; Gasparian A; Kitaeva M; Polotzky B; Tupitzin N; Machaladze Z; Gerasimov S; Shtutman M; Jakubovskaya M; Davidov M; Tatosyan A
Clin Exp Metastasis; 1996 Nov; 14(6):490-500. PubMed ID: 8970579
[TBL] [Abstract][Full Text] [Related]
9. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphism and cancer susceptibility.
Larsen CJ
Pathol Biol (Paris); 1989 Nov; 37(9):955-6. PubMed ID: 2575241
[No Abstract] [Full Text] [Related]
11. Increased frequency of specific alleles of the c-Ha-ras gene in Japanese cancer patients.
Honda K; Ishizaki K; Ikenaga M; Toguchida J; Inamoto T; Tanaka K; Ozawa K
Hum Genet; 1988 Aug; 79(4):297-300. PubMed ID: 2900800
[TBL] [Abstract][Full Text] [Related]
12. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
14. Molecular-genetic analysis of myc and c-Ha-ras proto-oncogene alterations in human carcinoma.
Knyazev PG; Fedorov SN; Serova OM; Pluzhnikova GF; Novikov LB; Kalinovsky VP; Seitz JF
Haematol Blood Transfus; 1987; 31():469-73. PubMed ID: 3327782
[No Abstract] [Full Text] [Related]
15. c-Ha-ras-1 alleles in bladder cancer, Wilms' tumour and malignant melanoma.
Hayward NK; Keegan R; Nancarrow DJ; Little MH; Smith PJ; Gardiner RA; Seymour GJ; Kidson C; Lavin MF
Hum Genet; 1988 Feb; 78(2):115-20. PubMed ID: 2892780
[TBL] [Abstract][Full Text] [Related]
16. Ha-ras polymorphisms in epithelial ovarian cancer.
O'Briant K; Chrysson N; Hunter V; Tyson F; Tanner M; Daly L; George SL; Berchuck A; Soper J; Fowler W
Gynecol Oncol; 1992 Jun; 45(3):299-302. PubMed ID: 1351862
[TBL] [Abstract][Full Text] [Related]
17. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
18. Ha-ras-1 alleles in Norwegian lung cancer patients.
Ryberg D; Tefre T; Ovrebø S; Skaug V; Stangeland L; Naalsund A; Baera R; Børresen AL; Haugen A
Hum Genet; 1990 Nov; 86(1):40-4. PubMed ID: 1979305
[TBL] [Abstract][Full Text] [Related]
19. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
Bouras M; Parvaz P; Berger N; Paulin C; Revol A
Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
